Illumina lowers Outlook due to China sales ban
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
Illumina recorded about $4.37 billion in total revenue during the 2024 fiscal year, down about 3% from the previous year.
Canaccord lowered the firm’s price target on Illumina (ILMN) to $115 from $135 and keeps a Hold rating on the shares. The firm’s target ...
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina ...
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments ...
Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results